Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way
Open Access
- 7 April 2015
- journal article
- review article
- Published by AVES YAYINCILIK A.Ş. in Journal of Breast Health
- Vol. 11 (2), 59-66
- https://doi.org/10.5152/tjbh.2015.1669
Abstract
Breast carcinoma comprises a group of diseases with specific clinical, histopathologic and molecular properties. Traditional classification use morphology to divide tumors into separate categories with differing behavior and prognosis. However, there are limitations of traditional classification systems, and new molecular methods are expected to improve classification systems. Molecular subtypes of breast carcinomas have been characterized in the last 11 years, and have been studied extensively. Much of the information accumulated in recent years, and molecular taxonomy seems to be still developing and undergoing change. The main question is whether new molecular techniques such as gene expression profiling will be accepted as gold standard in determining breast cancer subtypes, and whether molecular classification is useful in specific subtypes of breast cancer as it is in ductal carcinoma (nonspecific type). In addition, critical review of the literature reveals major problems such as poor definition, lack of reproducibility and lack of quality control in current molecular techniques and classifications. Therefore, current molecular approaches are not yet used in routine clinical practice and treatment guidance since they are immature and can even lead to incorrect assessment.Keywords
This publication has 57 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancerBreast Cancer Research and Treatment, 2012
- Microarray-Based Class Discovery for Molecular Classification of Breast Cancer: Analysis of Interobserver AgreementJNCI Journal of the National Cancer Institute, 2011
- Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinomaEuropean Journal of Cancer, 2010
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neckProceedings of the National Academy of Sciences of the United States of America, 2009
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast CancerJNCI Journal of the National Cancer Institute, 2009
- Lack of prognostic significance of “classic” lobular breast carcinoma: a matched, single institution seriesBreast Cancer Research and Treatment, 2008
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 2001
- Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy studyJournal of Surgical Oncology, 1991